"We look forward to investing in the business, further building out its scale and capabilities and becoming an increasingly valuable partner to our growing base of customers.". GTCR Appoints Don McDonough to Lead Business Development for its Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Financial Services & Technology, Growth Business Services, Healthcare, and Technology, Media & Telecommunications industries. Join Mergr to view GTCRs full profile and discover more Finally, we have a talented group of investment professionals and staff, and we are dedicated to providing our team with the most opportunity for professional growth and impact, while working in a collaborative and inclusive environment. GTCR - Investments, Portfolio & Company Exits - CrunchBase CHICAGO, Nov. 2, 2022 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has made a strategic, majority investment in Biocoat Holdings, LLC ("Biocoat" or the "Company"). Since 2018, equity firm GTCR has been included on a list of defendants on a long and growing list of personal injury lawsuits related to alleged toxic emissions from the Sterigenics facility in west suburban Willowbrook. You will be notified in advance of any changes in rate or terms. When typing in this field, a list of search results will appear and be automatically updated as you type. Piper Sandler served as exclusive financial advisor to Biocoat. GTCR is a private equity firm that typically partners with management when pursuing acquisitions. Our $684 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. This website uses cookies, including third-party cookies, in order to obtain information about your visit to the website and make this website better. Which industries has this organization most actively invested in? GTCR Investor Profile: Portfolio & Exits | PitchBook GTCR has a longstanding relationship with Mr. Hance, having originally partnered with him to form Regatta Medical in 2017 as a Leaders Strategy partnership to pursue opportunities in the medical device industry and acquired Resonetics, a leading medical device contract manufacturer, in February 2018. GTCR has made 42 investments. GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications sectors.
Address: Beijing, Haidian District, Xizhimen, Beida Street, Jia NO 43, Jinyun Building, Block B, Room 305-02
Contact number: +86-18518778855
Contact: Dr. Chenlong Gao
E-mail: he hasn't talked to me in a week after fight
Mobile:+86-18518778855